Akamis Bio
Phase 1Akamis Bio is working to advance the standard of care in colorectal cancer by developing oncolytic immunotherapies which aim to provide new hope to people living with this devastating disease.
Founded
2020
Focus
AntibodiesBiologicsVaccines
About
Akamis Bio is working to advance the standard of care in colorectal cancer by developing oncolytic immunotherapies which aim to provide new hope to people living with this devastating disease.
Funding History
1Total raised: $5M
Seed$5MUndisclosedNov 15, 2021
Company Info
TypePrivate
Founded2020
LocationLondon, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile